We are live on ! Find out more
DGX icon

Quest Diagnostics

975 hedge funds and large institutions have $17.5B invested in Quest Diagnostics in 2025 Q1 according to their latest regulatory filings, with 145 funds opening new positions, 317 increasing their positions, 340 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more first-time investments, than exits

New positions opened: 145 | Existing positions closed: 62

67% more capital inflows, than outflows

Capital inflows: $1.71B | Capital outflows: $1.03B

8% more funds holding

Funds holding: 902 → 975 (+73)

4.24% more ownership

Funds ownership: 89.08% → 93.31% (+4.2%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less repeat investments, than reductions

Existing positions increased: 317 | Existing positions reduced: 340

39% less call options, than puts

Call options by funds: $83.5M | Put options by funds: $136M

Holders
975
Holders Change
+73
Holders Change %
+8.09%
% of All Funds
13.01%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
145
Increased
317
Reduced
340
Closed
62
Calls
$83.5​M
Puts
$136​M
Net Calls
-⁠$52.3​M
Net Calls Change
-⁠$80.4​M

DGX Hedge Fund Activity: Q1 2025 in Review

975 of the 7,493 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q1 2025, worth a combined $17.5B — up 17% from $15B a quarter earlier.

Buyers outnumbered sellers: 145 funds opened new DGX positions and 62 closed out — a net gain of 83 holders — while 317 added to existing stakes and 340 trimmed.

The largest buyer was Boston Partners, opening a new position worth an estimated $377M. The largest seller was Millennium Management, cutting an estimated $105M.

  • 975 institutional investors held Quest Diagnostics (DGX) as of Q1 2025, up from 902 in Q4 2024.
  • Funds reported $17.5B of Quest Diagnostics stock for Q1 2025, up 17% quarter-over-quarter.
  • 145 funds opened new Quest Diagnostics positions in Q1 2025 and 62 closed out, a net change of +83 holders.
  • The largest Quest Diagnostics buyer in Q1 2025 was Boston Partners, an estimated $377M added.
  • The largest Quest Diagnostics seller in Q1 2025 was Millennium Management, an estimated $105M sold.

Based on aggregated 13F filings for Q1 2025.